Suppr超能文献

不同支气管扩张剂在哮喘中的作用比较。

A comparison of the actions of different bronchodilators in asthma.

作者信息

Freedman B J, Meisner P, Hill G B

出版信息

Thorax. 1968 Nov;23(6):590-7. doi: 10.1136/thx.23.6.590.

Abstract

The actions of the following pressurized bronchodilators were compared by administration to 24 asthmatics: (1) Medihaler Iso Forte, (2) Alupent, (3) Medihaler-duo, (4) Bronchilator, and (5) Prenomiser Plus. These contained one or more of the following: isoprenaline, orciprenaline, isoetharine, phenylephrine, atropine methonitrate, and thenyldiamine. The dose was a single discharge from the container. The response was assessed by calculating the mean percentage change in F.E.V. at intervals after inhalation. The mean peak rises were respectively (1) 49·4%, (2) 43·6%, (3) 36·2%, (4) 33·5%, and (5) 23·5%. The amplitude of peak response to isoprenaline was related to the logarithm of the dose. Weight for weight, orciprenaline had a peak bronchodilator activity 41·5% that of isoprenaline and isoetharine 50%. The preparations did not differ significantly in the time taken to reach maximum response, which varied from 5 to 60 minutes; three-quarters of the maxima occurred within 15 minutes. The half-life for Alupent was 2 hours; for Medihaler-duo, which contains 240 μg. of phenylephrine per dose, it was 1¼ hours; for the remaining preparations it was about 1 hour. The decay rate, after the first half-hour, was 6% of the basal F.E.V. per hour for Medihaler-duo; for the other preparations it was 10-12%. In the doses given, Alupent yielded 20% and 30% increases lasting 130 and 67 minutes; after Medihaler Iso Forte these lasted 78 and 46 minutes. Similar comparative experiments, designed to eliminate effects of dosage difference, are desirable. Rebound bronchoconstriction occurred in 23% of 92 experiments. There was no response to propellent alone. The mean percentage change in F.E.V. may not be the best way of expressing results.

摘要

对24名哮喘患者使用以下几种加压支气管扩张剂并比较其作用:(1) 强力异丙肾上腺素定量气雾剂;(2) 间羟异丙肾上腺素;(3) 异丙肾上腺素-阿托品定量气雾剂;(4) 支气管扩张剂;(5) 普瑞诺米赛加强型。这些药物含有以下一种或多种成分:异丙肾上腺素、间羟异丙肾上腺素、异他林、去氧肾上腺素、硝酸甲胆碱阿托品和茶苯海明。剂量为容器的单次喷出量。通过计算吸入后不同时间点第一秒用力呼气量(F.E.V.)的平均百分比变化来评估反应。平均峰值上升分别为:(1) 49.4%;(2) 43.6%;(3) 36.2%;(4) 33.5%;(5) 23.5%。对异丙肾上腺素的峰值反应幅度与剂量的对数相关。按重量计算,间羟异丙肾上腺素的峰值支气管扩张活性为异丙肾上腺素的41.5%,异他林为50%。这些制剂达到最大反应所需时间无显著差异,时间从5分钟到60分钟不等;四分之三的最大值出现在15分钟内。间羟异丙肾上腺素的半衰期为2小时;异丙肾上腺素-阿托品定量气雾剂每剂含240μg去氧肾上腺素,其半衰期为1.25小时;其余制剂的半衰期约为1小时。半小时后,异丙肾上腺素-阿托品定量气雾剂的衰减率为每小时基础F.E.V.的6%;其他制剂为10%-12%。在给定剂量下,间羟异丙肾上腺素产生20%和30%的增加,持续130分钟和67分钟;强力异丙肾上腺素定量气雾剂给药后,增加持续78分钟和46分钟。需要进行类似的比较实验以消除剂量差异的影响。在92次实验中,23%出现了反跳性支气管收缩。单独使用抛射剂无反应。F.E.V.的平均百分比变化可能不是表达结果的最佳方式。

相似文献

3
The effect of bronchodilator aerosols on the peak expiratory flow rate in asthmatic patients.
Acta Med Scand. 1966 Oct;180(4):421-7. doi: 10.1111/j.0954-6820.1966.tb02854.x.
4
IPPB therapy with bronkospray or isoproterenol--a comparison.
J Asthma Res. 1967 Mar;4(3):197-204. doi: 10.3109/02770906709100547.
5
A comparison of the actions of different bronchodilators in asthma.
Int Arch Allergy Appl Immunol. 1969;36(1):186-90. doi: 10.1159/000230740.
10

引用本文的文献

2
On a New Approach to Assess Bronchodilator Responsiveness.一种评估支气管扩张剂反应性的新方法。
Ann Am Thorac Soc. 2021 May;18(5):909-913. doi: 10.1513/AnnalsATS.202008-966RL.

本文引用的文献

6
VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN.
Thorax. 1964 Sep;19(5):406-15. doi: 10.1136/thx.19.5.406.
7
SPIROMETRIC INTEGRALS AFTER ISOPRENALINE AND ATROPINE IN ASTHMA.
Br J Dis Chest. 1964 Oct;58:174-80. doi: 10.1016/s0007-0971(64)80004-8.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验